Aflib_8_mg_6_months_intervals_in_EU_ _thumbnail
June 30, 2025

Eylea 8 mg approved in EU for 6-month dosing in nAMD and DME

EU expands Eylea 8 mg label to include longer intervals for nAMD and DME The European Commission (EC) has approved…

Discover our fascinating content at issuu

explore